Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2012
04/11/2012CN102408408A 具有抗肿瘤作用的芳基脲衍生物 Aryl urea derivatives having anti-tumor effects
04/11/2012CN101535273B 治疗增生性疾病的6-氧代-1,6-二氢嘧啶-2-基化合物 The treatment of proliferative diseases 6-oxo-1,6-dihydro-pyrimidin-2-yl compound
04/10/2012US8153793 Sulfonamide derivative having PGD2 receptor antagonistic activity
04/10/2012US8153791 substituted pyrimidine compoundssuch as 4-amino-6-(3-chloro-4-fluoro-phenylamino)-pyrimidine-5-carbaldehyde O-methyl oxime, used for treating, preventing or ameliorating a chronic or acute protein kinase mediated diseasea, disorders or conditions
04/10/2012US8153678 Process for preparing A 3-pyrrole substituted 2-indolinone malate salt
04/10/2012US8153673 Metalloproteinase inhibitors
04/10/2012US8153669 Quaternary ammonium salts as M3 antagonists
04/10/2012US8153655 Compositions useful as inhibitors of voltage-gated sodium channels
04/10/2012US8153652 Fab I inhibitors
04/10/2012US8153643 Quinazoline derivatives
04/10/2012US8153642 Quinazolines useful as modulators of ion channels
04/10/2012US8153638 Metabotropic glutamate-receptor-potentiating isoindolones
04/10/2012US8153634 Carbinol derivatives having cyclic linker
04/10/2012US8153631 Triazole compounds and uses related thereto
04/10/2012US8153630 of Aurora-2 (Aurora-A) protein kinase; anticancer; 6-(pyrazolylamino)-4-pyrimidine carboxamides; Methyl 2-(4-cyclopropanecarboxamidophenylsulfanyl)-5-amino-6-(5-methylpyrazol-3-ylamino)-4-pyrimidinecarboxylate
04/10/2012US8153628 Pyrazolyl substituted xanthines
04/10/2012US8153625 Nitrogen-containing heterocyclic compounds and medicinal use thereof
04/10/2012US8153622 8-substituted benzoazepines as toll-like receptor modulators
04/10/2012CA2497725C Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
04/10/2012CA2486308C Hepatitis c virus inhibitors
04/05/2012WO2012044613A1 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
04/05/2012WO2012044595A1 Dabigatran etexilate bismesylate salt, solid state forms and process for preparation thereof
04/05/2012WO2012044537A1 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators
04/05/2012WO2012044531A1 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
04/05/2012WO2012044520A1 Solid state forms of a potent hcv inhibitor
04/05/2012WO2012044090A2 Novel aminoquinazoline compound having a protein-kinase inhibiting action
04/05/2012WO2012043791A1 1,2,4-triazolone derivative
04/05/2012WO2012041524A1 Hydrazonopyrazolones as protein tyrosine phosphatase inhibitors
04/05/2012WO2012041435A1 Phenylquinazoline derivatives
04/05/2012WO2012041158A1 Tricyclic compound, preparation method and pharmaceutical use thereof
04/05/2012WO2012024419A3 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
04/05/2012WO2011149620A3 Synthesis of triazole-based and imidazole-based zinc catalysts
04/05/2012WO2011121418A9 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
04/05/2012US20120083605 Pyridazine compound and use thereof
04/05/2012US20120083603 High stability polyionic liquid salts
04/05/2012US20120083557 Sterically hindered amine stabilizers
04/05/2012US20120083500 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x 2/3 antagonists
04/05/2012US20120083495 Compounds for the treatment of spinal muscular atrophy and other uses
04/05/2012US20120083494 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
04/05/2012US20120083488 Tetracyclic compound
04/05/2012US20120083475 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
04/05/2012US20120083474 Heterocyclic amides as modulators of trpa1
04/05/2012US20120082621 Swallowtail motifs for imparting water solubility to porphyrinic compounds
04/05/2012US20120080585 Photoelectric conversion element, production method thereof, photosensor, imaging device and their driving method
04/05/2012CA2813256A1 Aryl-substituted imidazoles
04/05/2012CA2813179A1 Solid state forms of a potent hcv inhibitor
04/05/2012CA2812935A1 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
04/05/2012CA2812859A1 Phenylquinazoline derivatives
04/05/2012CA2811192A1 1,2,4-triazolone derivative
04/05/2012CA2810077A1 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
04/04/2012EP2436682A1 Co-crystals and pharmaceutical compositions comprising the same
04/04/2012EP2436676A1 Human adam-10 inhibitors
04/04/2012EP2436673A1 Curcumin derivatives with improved physicochemical properties and nanoliposomes surface-decorated with the derivatives with very high affinity for amyloid-beta1-42 peptide
04/04/2012EP2436396A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
04/04/2012EP2435435A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435429A1 Hepatitis c virus inhibitors
04/04/2012EP2435425A1 Hepatitis c virus inhibitors
04/04/2012EP2435424A1 Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
04/04/2012EP2435423A1 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
04/04/2012EP2435422A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435421A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
04/04/2012EP2435420A1 Pyrazinylpyrazoles
04/04/2012EP2435048A1 Radiolabeled pde10 inhibitors
04/04/2012EP2193112B1 Electroluminescent device
04/04/2012EP1466890B1 Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes
04/04/2012EP1316316B1 Preparations for oral administration
04/04/2012CN1930143B 具有微粒体甘油三酸酯传递蛋白质抑制活性的被五元杂环取代的芳基哌啶或哌嗪 Having microsomal triglyceride transfer protein inhibiting activity by five-membered heterocyclic aryl substituted piperidine or piperazine
04/04/2012CN102405212A 在体内外使用的偶联识别/检测系统 Coupling for use in vivo identification / detection system
04/04/2012CN102405211A Proline derivatives as cathepsin inhibitors
04/04/2012CN101217957B 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2
04/03/2012US8148539 Cyanine dye labelling reagents
04/03/2012US8148531 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
04/03/2012US8148525 2,4-pyrimidinediamine compounds and their uses
04/03/2012US8148422 Sulfonamides as TRPM8 modulators
04/03/2012US8148413 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
04/03/2012US8148390 Monocyclic anilide spirolactam CGRP receptor antagonists
04/03/2012US8148367 Renin inhibitors
04/03/2012US8148363 Heterocyclic compounds as factor IXA inhibitors
04/03/2012US8147987 Organic electroluminescent element and compounds for use in the element
04/03/2012US8147818 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
03/2012
03/29/2012WO2012040389A2 Substituted bicyclic hcv inhibitors
03/29/2012WO2012040258A2 Therapeutic piperazines
03/29/2012WO2012040242A1 Substituted proline inhibitors of hepatitis c virus replication
03/29/2012WO2012039717A1 Hepatitis c virus inhibitors
03/29/2012WO2012039561A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/29/2012WO2012039371A1 Cyclopropane compound
03/29/2012WO2012038942A1 Matrix metalloproteinase inhibitors
03/29/2012WO2012038417A1 Substituted amino - benzoic acid derivatives as inhibitors of dna methyltransferases
03/29/2012WO2012013282A8 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k
03/29/2012WO2011119777A3 Compositions and methods for treatment of neurodegenerative disease
03/29/2012WO2011060877A3 Materials for organic light emitting devices
03/29/2012US20120077988 Branched hetero polyethylene glycol and intermediate
03/29/2012US20120077985 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
03/29/2012US20120077811 Prodrug forms of kinase inhibitors and their use in therapy
03/29/2012US20120077797 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
03/29/2012US20120077759 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
03/29/2012US20120077711 Novel Ligands and Libraries of Ligands
03/29/2012US20120076835 Hiv inhibiting pyrimidines derivatives
03/29/2012US20120076756 Novel benzimidazole derivatives
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 626